Dr. Sutapa Mukherjee Senior Scientific Officer(Asst. Dir Gr.)
Department: Cancer Research
Education
Academic
Qualifications
- PhD in Science: Jadavpur University, 2005.
- M.Sc in Life Science (Zoology): Visva Bharati, Santiniketan,
1998.
- B.Sc in Life Science (Zoology): Visva Bharati, Santiniketan, 1996.
Administrative
& Professional Positions
- Head of Department: Environmental Carcinogenesis
& Toxicology, CNCI (2022-Present)
- Member Secretary: Institutional IEC (2022–Present).
- Nodal Officer: CSIR HRDG Fellow (2022-Present).
- Ex Academic Coordinator: CNCI (2013–2021).
- Ex Central Public Information Officer: CNCI (2016–2018).
Professional Summary
A senior scientist and department head with extensive expertise in molecular oncology and environmental toxicology. Leading research focused on identifying the key factors for overcoming chemo/radio-resistance in various cancers.
- Email: sutapamukherjee@cnci.ac.in | sutapa_c_in@yahoo.com
- ORCID-ID: 0000-0002-4411-7257
- Google Scholar ID: https://scholar.google.com/citations?user=7NLkGyYAAAAJ&hl=en
Research Specialization
- Phytochemical Chemoprevention
- Apoptosis & Caspase Signaling
- Chemo/Radio-Resistance Reversal
- PI3K/Akt and other Serine Threonine
Kinases (Aurora Kinases) Signaling & EMT
- Altered telomerase and
mitochondrial dynamics in cancer
- Metabolic Reprogramming in Cancer
Select Research Projects
Ongoing
Projects:
- PI: Unraveling the Potential
Therapeutic Impact of Biguanide Derivatives on EGFR/HER2-enriched Breast
Cancer with a Special Emphasis on TERT-mediated Mitochondrial Dynamics (CSIR-ASPIRE,
2024–Present).
- PI: Assessment of Plasticity of
Glutamine Metabolism to Determine Cisplatin Therapy Response in Cervical
Cancer Cohorts of Eastern and North-Eastern India (DHR, Govt of India,
2023–Present).
- PI: Crosstalk between Glucocorticoid Receptor and Stemness Factors in Breast Cancer (CNCI Intramural, 2021–2024).
Notable
Completed Projects:
- PI: Modulation of therapeutic targets
Aurora kinases A and B by phytochemicals in breast cancer cells (DST,
2015–2019).
- PI: Role of natural histone deacetylase inhibitors towards sensitization of tumor cells (DST SERC Fast Track, 2008–2011).
Publications
& Scholarly Impact
- Total Publications: 57.
- Cumulative Impact Factor: 94.944.
Featured Recent Papers
- Aurora Kinase A inhibitor alisertib
failed to exert its efficacy on TNBC cells due to consequential enrichment
of polyploid giant cancer cells (PGCCs), Discover Oncology, 16,
2043 (2025). https://doi.org/10.1007/s12672-025-03825-0
- Polysaccharide Extract of Ganoderma
resinaceum Restricts Breast Cancer Progression..., Rev. Bras.
Farmacogn. 35, 1404–1424 (2025). https://doi.org/10.1007/s43450-025-00702-3
- Glucocorticoid Receptor Interacts
with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer, Journal
of Current Oncological Trends, 2024.
- Restoration of radiosensitivity by
Genistein, a soya isoflavone is accomplished by facilitating DNA damage
response in radio-resistant cervical cancer in vitro. Journal of
Radiation and Cancer Research; 15(4):p 200-210, Oct–Dec 2024.
- Glucocorticoid receptor: a
harmonizer of cellular plasticity in breast cancer—directs the road
towards therapy resistance, metastatic progression and recurrence. Cancer
Metastasis Rev 43, 481–499 (2024). https://doi.org/10.1007/s10555-023-10163-6
- Refashioning of the drug-properties
of fluoroquinolone through the synthesis of a levofloxacin-imidazole
cobalt (II) complex and its interaction studies on with DNA and BSA
biopolymers, antimicrobial and cytotoxic studies on breast cancer cell
lines. International journal of biological macromolecules, 253(Pt
8), 127636 (2023). https://doi.org/10.1016/j.ijbiomac.2023.127636.
- Black tea extract prevents
inorganic arsenic induced uncontrolled proliferation, epithelial to
mesenchymal transition and induction of metastatic properties in HaCaT
keratinocytes - an in vitro study. Toxicology in vitro: an international
journal published in association with BIBRA, 85, 105478 (2022). https://doi.org/10.1016/j.tiv.2022.105478
- Aspirin Restores Radiosensitivity
in Cervical Cancer Cells by Inducing Mitotic Catastrophe through
Downregulating G2/M Effectors. Asian Pac J Cancer Prev. 2022 Nov
1;23(11):3801-3813. 10.31557/APJCP.2022.23.11.3801
- Synthesis of Cu(II)-Caffeine
Complex as potential therapeutic Agent: Studies on Antioxidant, anticancer
and pharmacological activities. J Mol Liquids Volume 364, 15
October 2022, 119897.
- Phenethylisothiocyanate Potentiates
Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer. Frontiers
in Pharmacology (2022), 13, 803114. https://doi.org/10.3389/fphar.2022.803114
Professional Engagements & Awards
- Young Scientist Award: Indian Science Congress, 2005.
- Reviewer: iScience (Cell Press), Scientific
Reports, Frontiers in Oncology, Molecular Cellular
Biochemistry, BMC Cancer, Cancer Cell International
- Memberships: Indian Association for Cancer
Research (IACR), Society for Biological Chemists (SBC), and Environmental
Mutagen Society of India (EMSI), Japanese Cancer Association (Annual
Member)
Present Team Members
|
Mr.
Debanjan Thakur |
SRF
(Institute) |
|
Mr.
Dipan Sarkar |
Project
Associate-I (DHR Project)
|
|
Mr.
Arka Laha |
J.R.F
(CSIR-ASPIRE) Project |
|
Ms
Mampy Ghosh |
UGC-JRF |
Past Team
|
Dr.
Debomita Sengupta |
CSIR-SRA |
|
Dr.
Archisman Ghosh |
PhD
Completed |
|
Dr.
Elizabeth Mahapatra |
PhD
Completed |
|
Dr.
Sipping Kemegne Marius Tresor |
Sandwich Fellowship Program (TWAS-DBT) |
|
Mr.
Souvick Biswas |
Thesis submitted |
|
Ms
Salini Das |
CSIR-SRF |



